In animal model to study FLT3-ITD, Quizartinib has been described as a potent and selective inhibitor of FLT3 to treat mice bearing human AML xenografts34, in which there is a constitutive phosphorylation of FLT3 due to the ITD. Here, FLT3 is linked to acute myeloid leukemia.